Safety and Performance Evaluation of Tulip Device in Healthy Overweight and Obese Volunteers

NCT01753609 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2012-12-20

No results posted yet for this study

Summary

The study will assess the safety and performance of an intragastric auto-inflating and degradable balloon

Conditions

Interventions

DEVICE

Tulip capsule

swallowing Tulip capsule for up to 29 days

Sponsors & Collaborators

  • Tulip Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Sigal Fishman, Dr. · Tel Aviv Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-03-31
Completion
2013-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01753609 on ClinicalTrials.gov